MedTrace Logo

Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products

NCT02289612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-05-08

No results posted yet for this study

Summary

The purpose of this study is to determine the specific properties of a variety of dietary fibres that lead to different postprandial glycemic and satiety responses in individuals at risk for type 2 diabetes. This is accomplished by utilizing a variety of dietary fibres that demonstrate a wide range of properties in a pudding product, and by examining the ability of each of these to limit gastric emptying, limit glucose absorption, limit insulin secretion, and improve satiety, versus a low fibre control product.

Conditions

Interventions

OTHER

Yellow Mustard Gum Fibre

OTHER

Soluble Flaxseed Gum Fibre

OTHER

Fenugreek Gum Fibre

Sponsors & Collaborators

  • Ontario Ministry of Agriculture, Food and Rural Affairs

    collaborator OTHER_GOV

  • Natural Sciences and Engineering Research Council, Canada

    collaborator OTHER

  • Dairy Farmers of Ontario

    collaborator OTHER

  • Agriculture and Agri-Food Canada

    collaborator OTHER_GOV

  • University of Guelph

    lead OTHER

Principal Investigators

  • Alison M Duncan, Ph.D., R.D. · University of Guelph, Human Nutraceutical Research Unit

  • Amanda J Wright, Ph.D. · University of Guelph, Human Nutraceutical Research Unit

  • Alison M Duncan, Ph.D., R.D. · University of Guelph, Human Nutraceutical Research Unit

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02289612 on ClinicalTrials.gov